[2024 US Bio]DBPR22998/ A QPCTL (IsoQC) Inhibitor Targeting CD47-SIRPα Axis- Novel innate immune checkpoint inhibitor

DBPR22998/ A Potent QPCTL (IsoQC) Inhibitor Targeting CD47-SIRPα Axis for Cancer Immunotherapy

  • Tel:+886-37-206166 #33201
  • Fax：+886-37-583287
  • Adress：No.35, Keyan Rd., Zhunan Township, Miaoli County 350 ,Taiwan